TLDR Platelet-rich fibrin may help reduce nonmelanoma skin cancer cell growth.
This study explores the effects of platelet-rich fibrin (PRF) on nonmelanoma skin cancer cells, specifically basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). PRF treatment significantly reduced cell viability and proliferation, particularly in BCC cells, by inducing cell cycle arrest and activating apoptotic pathways. This was evidenced by the downregulation of CCND1 and upregulation of p21, p53, caspase-8, and caspase-9 gene expressions. The study suggests that PRF may have tumor-suppressive effects, offering a promising basis for future research into its use in managing localized skin cancers.
July 2024 in “Periodontology 2000” Autologous platelet concentrates show promise in esthetic treatments but need more standardized research.
1 citations
,
November 2022 in “Journal of Dermatological Treatment” Platelet-rich plasma can increase hair density and may help treat some skin conditions, but it's costly, not FDA-approved, and needs more research.
10 citations
,
September 2021 in “International Journal of Nanomedicine” Tiny particles called extracellular vesicles show promise for treating skin conditions and promoting hair growth.
January 2022 in “Dermatology Review” Higher IL-31 levels are linked to worse itching in chronic kidney disease patients.
12 citations
,
October 2023 in “International Journal of Molecular Sciences” Understanding how skin cells react to pressure can help diagnose and manage pressure-related skin disorders.
6 citations
,
July 2023 in “Diabetology” Autologous micrografts significantly improve wound healing in diabetic conditions by speeding up tissue regeneration and reducing inflammation.
306 citations
,
April 2019 in “International Journal of Molecular Sciences” The skin has a complex immune system that is essential for protection and healing, requiring more research for better wound treatment.